机构:[1]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, People’s Republic of China四川大学华西医院[2]Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, People’s Republic of China外科中心胸外科中心四川省肿瘤医院胸外科[3]Department of Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, People’s Republic of China四川大学华西医院
Natural Science Foundation of Sichuan Province (2022NSFSC1464, 2023NSFSC1893) and Post-Doctor Research Project, West China Hospital, Sichuan University (2021HXBH072).
第一作者机构:[1]Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, People’s Republic of China[3]Department of Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, People’s Republic of China
通讯作者:
推荐引用方式(GB/T 7714):
Wang Yan,Song Wenpeng,Wang Xin,et al.Does the presence of a micropapillary component predict worse prognosis in pathological stage IA lung adenocarcinoma?[J].PATHOLOGY RESEARCH AND PRACTICE.2023,242:doi:10.1016/j.prp.2023.154314.
APA:
Wang Yan,Song Wenpeng,Wang Xin&Che Guowei.(2023).Does the presence of a micropapillary component predict worse prognosis in pathological stage IA lung adenocarcinoma?.PATHOLOGY RESEARCH AND PRACTICE,242,
MLA:
Wang Yan,et al."Does the presence of a micropapillary component predict worse prognosis in pathological stage IA lung adenocarcinoma?".PATHOLOGY RESEARCH AND PRACTICE 242.(2023)